We are live on ! Find out more
NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.23B
1-Year Est. Return 81.32%
This Fund
S&P 500
This Quarter Est. Return
-38.81%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$710M
AUM Growth
-$549M
Cap. Flow
-$991K
Cap. Flow %
-0.14%
Top 10 Hldgs %
88.11%
Holding
25
New
2
Increased
4
Reduced
5
Closed
2

Top Buys

Rank Stock Value
1
SIBN icon
SI-BONE Inc
SIBN
+$16.9M
2
INSP icon
Inspire Medical Systems
INSP
+$7.44M
3
SPNE
SeaSpine Holdings Corporation Common Stock
SPNE
+$5.49M
4
FOLD
Amicus Therapeutics
FOLD
+$2.42M
5
AERI
Aerie Pharmaceuticals
AERI
+$1.98M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$11.5M
2
IVTY
Invuity, Inc
IVTY
+$8.95M
3
MRUS
Merus
MRUS
+$8.69M
4
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$4.07M
5
VYNE icon
VYNE Therapeutics
VYNE
+$1.03M

Sector Composition

Rank Sector Weight
1 Healthcare 91.94%
2 Financials 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INGN icon
1
Inogen
INGN
$171M
$441M 62.05%
3,549,320
– –
GKOS icon
2
Glaukos
GKOS
$8.92B
$34M 4.79%
605,266
+2,557
+0.4% +$154K
SPNE
3
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$23.9M 3.36%
1,308,037
+325,000
+33% +$5.49M
KIDS icon
4
OrthoPediatrics
KIDS
$509M
$22.8M 3.21%
654,549
– –
SIBN icon
5
SI-BONE Inc
SIBN
$756M
$18.6M 2.63%
+892,684
New +$16.9M
XLRN
6
DELISTED
Acceleron Pharma
XLRN
$18.3M 2.58%
420,293
-229,707
-35% -$11.5M
FOLD
7
DELISTED
Amicus Therapeutics
FOLD
$17.9M 2.52%
1,867,870
+220,000
+13% +$2.42M
AKBA icon
8
Akebia Therapeutics
AKBA
$343M
$17.1M 2.41%
3,100,000
– –
AERI
9
DELISTED
Aerie Pharmaceuticals
AERI
$16.3M 2.29%
450,714
+42,152
+10% +$1.98M
CRVS icon
10
Corvus Pharmaceuticals
CRVS
$1.09B
$16.2M 2.28%
4,420,516
– –
DERM
11
DELISTED
Dermira, Inc.
DERM
$14.3M 2.02%
1,993,746
– –
STIM icon
12
Neuronetics
STIM
$126M
$10.2M 1.43%
525,000
– –
ETTX
13
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$8.88M 1.25%
2,181,843
– –
LKFT
14
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$8.03M 1.13%
87,481
– –
INSP icon
15
Inspire Medical Systems
INSP
$1.47B
$7.39M 1.04%
+175,000
New +$7.44M
VRNA
16
DELISTED
Verona Pharma
VRNA
$7.15M 1.01%
740,740
– –
MRUS
17
DELISTED
Merus
MRUS
$7.04M 0.99%
502,795
-600,000
-54% -$8.69M
NBRV
18
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$6.87M 0.97%
18,815
– –
VYNE icon
19
VYNE Therapeutics
VYNE
$19.1M
$5.23M 0.74%
353
-46
-12% -$1.03M
CRNX icon
20
Crinetics Pharmaceuticals
CRNX
$8.87B
$4.05M 0.57%
135,009
-14,991
-10% -$422K
C icon
21
Citigroup
C
$223B
$2.73M 0.38%
52,500
– –
COGT icon
22
Cogent Biosciences
COGT
$6.91B
$2.5M 0.35%
142,258
-24,037
-14% -$711K
WMGIZ
23
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
– –
0
– –
RARX
24
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-225,000
Closed -$4.07M
IVTY
25
DELISTED
Invuity, Inc
IVTY
– –
-1,209,854
Closed -$8.95M

Similar funds

HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Novo Holdings A/S's Q4 2018 Portfolio in Review

As of Q4 2018, Novo Holdings A/S held 25 positions worth $710M, down 44% from $1.26B the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Novo Holdings A/S's Q4 2018 filing shows 2 new, 4 increased, 5 reduced and 2 closed positions. Its largest new stake was SI-BONE Inc: 892,684 shares worth $18.6M. The largest sale was Acceleron Pharma, an estimated $11.5M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, down from 94% a quarter earlier, followed by Financials.

  • Novo Holdings A/S's largest Q4 2018 buy was SI-BONE Inc: 892,684 shares worth $18.6M.
  • Novo Holdings A/S added most to SeaSpine Holdings Corporation Common Stock in Q4 2018, an estimated $5.49M increase.
  • Novo Holdings A/S's biggest Q4 2018 reduction was Acceleron Pharma, cutting an estimated $11.5M.
  • Novo Holdings A/S fully exited Invuity, Inc in Q4 2018, selling an estimated $8.95M.
  • Novo Holdings A/S's ten largest holdings make up 88% of its $710M portfolio in Q4 2018.
  • Novo Holdings A/S opened 2 new positions and closed 2 in Q4 2018.
  • Novo Holdings A/S's portfolio value fell 44% quarter-over-quarter to $710M.

Based on Novo Holdings A/S's 13F filing for Q4 2018, filed 14 Feb 2019.